UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.531

Sortiert nach

TXL-Fuzz: A Long Attention Mechanism-Based Fuzz Testing Model for Industrial IoT Protocols

IEEE internet of things journal, 2024-08, p.1-1

2024

Volltextzugriff (PDF)

SAT-356 - Assessing the in vitro anti-HBV activity of combinations including CRV431, TXL, and prototype capsid assembly modulators

Journal of hepatology, 2018-04, Vol.68, p.S768-S768

2018

Volltextzugriff (PDF)

Assessing the in vitro anti-HBV activity of combinations including CRV431, TXL, and prototype capsid assembly modulators

Journal of hepatology, 2018-04, Vol.68, p.S768

2018

Volltextzugriff (PDF)

Preparation of Sea Anemone Peptide Toxin Ap-Txl and Its Insecticidal Activity

Agricultural biotechnology (Pawtucket, R.I.), 2022-10, Vol.11 (5), p.130-133

2022

Volltextzugriff (PDF)

Tongxinluo (TXL), a Traditional Chinese Medicinal Compound, Improves Endothelial Function After Chronic Hypoxia Both In Vivo and In Vitro

Journal of cardiovascular pharmacology, 2015-06, Vol.65 (6), p.579-586

2015

Volltextzugriff (PDF)

Retrospective observational analysis of bevacizumab (BV) plus paclitaxel (TXL) as first line treatment in metastatic HER2 negative breast cancer (BC): are BV long responders a different subgroup?

Annals of oncology, 2016-09, Vol.27, p.iv70

2016

Volltextzugriff (PDF)

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking (TXL) for Myopia

Journal of visualized experiments, 2018-01 (131)

2018

Volltextzugriff (PDF)

Agile Parsing in TXL

Automated software engineering, 2003-10, Vol.10 (4), p.311-336

2003

Volltextzugriff (PDF)

Impact of response to induction chemotherapy (CT) and prior paclitaxel (TXL)-based CT on the outcome of salvage high-dose chemotherapy (HDCT) for relapsed germ-cell tumors (GCT) in the modern era: An EBMT Solid Tumors Working Party study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.4535-4535

2015

Volltextzugriff (PDF)

Chinese patent medicine Tongxinluo: A review on chemical constituents, pharmacological activities, quality control, and clinical applications

Phytomedicine (Stuttgart), 2024-09, Vol.132, p.155674, Article 155674

2024

Volltextzugriff (PDF)

Treatment of HER2-negative metastatic breast cancer (MBC) with bevacizumab (BEV) plus paclitaxel (TXL): A single-center phase II study

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e11509-e11509

2011

Volltextzugriff (PDF)

Automated Generation of Language Use Vector Extractors from TXL Grammars

Vishwambar, Karthik

2019

Volltextzugriff (PDF)

Final overall survival results of NEJ002, a phase III trial comparing gefitinib to carboplatin (CBDCA) plus paclitaxel (TXL) as the first-line treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutations

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7519-7519

2011

Volltextzugriff (PDF)

Pattern Analysis of TXL Programs

Rahman, Ashiqur

2015

Volltextzugriff (PDF)

P-122 高齢者非小細胞肺癌に対するCBDCA＋TXL週1回投与法とCBDCA＋TXL一括投与法との無作為化第II相試験

肺癌, 2008-10, Vol.48 (5), p.520-520

2008

Volltextzugriff (PDF)

First-line gefitinib versus first-line chemotherapy by carboplatin (CBDCA) plus paclitaxel (TXL) in non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations: A phase III study (002) by North East Japan Gefitinib Study Group

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8016-8016

2009

Volltextzugriff (PDF)

TXL ([Airline])

A Dictionary of Abbreviations, 2011

Burt Vance

1, 2011

Volltextzugriff (PDF)

Multicenter phase II study of triple combination with S-1 and cisplatin (CDDP) plus paclitaxel (TXL) in patients with advanced gastric cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.4539-4539

2008

Volltextzugriff (PDF)

Follow up of a multicenter phase II study of sequential paclitaxel and S-1 (TXL/S1) as postoperative adjuvant chemotherapy for gastric cancer (GC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.15084-15084

2007

Volltextzugriff (PDF)

Tian Xian Liquid (TXL) induces apoptosis in HT-29 colon cancer cell in vitro and inhibits tumor growth in vivo

Chinese medicine, 2010-07, Vol.5 (1), p.25-25, Article 25

2010

Volltextzugriff (PDF)

A multicenter phase II study of sequential paclitaxel and S-1 (TXL/S-1) as postoperative adjuvant chemotherapy for gastric cancer (GC)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4067-4067

2005

Volltextzugriff (PDF)

P-247: Low dose extended release metoprolol (Toprol-XL®, TXL) is effective and well tolerated add-on antihypertensive therapy

American journal of hypertension, 2005-05, Vol.18 (S4), p.94A-95A

2005

Volltextzugriff (PDF)

Evolving TXL

Thurston, Adrian

2005

Volltextzugriff (PDF)

TXL ([Airport Code])

A Dictionary of Abbreviations, 2011

Burt Vance

1, 2011

Volltextzugriff (PDF)

Phase I study of paclitaxel (TXL), doxorubicin (ADM) and carboplatin (CBDCA) combination therapy (TAC) in patients with high-risk and recurrent endometrial cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.5084-5084

2005

Volltextzugriff (PDF)

1 – 25 von 4.531

Suche als RSS-Feed

Aktive Filter

KollektionNexis Uni

KollektioneBooks on EBSCOhost

Zeitschrift / SerieMnemosyne

SpracheTürkisch

ThemaFemale

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.041)
Mit Volltextzugriff
(2.629)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

14 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

TXL-Fuzz: A Long Attention Mechanism-Based Fuzz Testing Model for Industrial IoT Protocols

SAT-356 - Assessing the in vitro anti-HBV activity of combinations including CRV431, TXL, and prototype capsid assembly modulators

Assessing the in vitro anti-HBV activity of combinations including CRV431, TXL, and prototype capsid assembly modulators

Preparation of Sea Anemone Peptide Toxin Ap-Txl and Its Insecticidal Activity

Tongxinluo (TXL), a Traditional Chinese Medicinal Compound, Improves Endothelial Function After Chronic Hypoxia Both In Vivo and In Vitro

Retrospective observational analysis of bevacizumab (BV) plus paclitaxel (TXL) as first line treatment in metastatic HER2 negative breast cancer (BC): are BV long responders a different subgroup?

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking (TXL) for Myopia

Agile Parsing in TXL

Impact of response to induction chemotherapy (CT) and prior paclitaxel (TXL)-based CT on the outcome of salvage high-dose chemotherapy (HDCT) for relapsed germ-cell tumors (GCT) in the modern era: An EBMT Solid Tumors Working Party study

Chinese patent medicine Tongxinluo: A review on chemical constituents, pharmacological activities, quality control, and clinical applications

Treatment of HER2-negative metastatic breast cancer (MBC) with bevacizumab (BEV) plus paclitaxel (TXL): A single-center phase II study

Automated Generation of Language Use Vector Extractors from TXL Grammars

Final overall survival results of NEJ002, a phase III trial comparing gefitinib to carboplatin (CBDCA) plus paclitaxel (TXL) as the first-line treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutations

Pattern Analysis of TXL Programs

P-122 高齢者非小細胞肺癌に対するCBDCA＋TXL週1回投与法とCBDCA＋TXL一括投与法との無作為化第II相試験

First-line gefitinib versus first-line chemotherapy by carboplatin (CBDCA) plus paclitaxel (TXL) in non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations: A phase III study (002) by North East Japan Gefitinib Study Group

TXL ([Airline])

Multicenter phase II study of triple combination with S-1 and cisplatin (CDDP) plus paclitaxel (TXL) in patients with advanced gastric cancer

Follow up of a multicenter phase II study of sequential paclitaxel and S-1 (TXL/S1) as postoperative adjuvant chemotherapy for gastric cancer (GC)

Tian Xian Liquid (TXL) induces apoptosis in HT-29 colon cancer cell in vitro and inhibits tumor growth in vivo

A multicenter phase II study of sequential paclitaxel and S-1 (TXL/S-1) as postoperative adjuvant chemotherapy for gastric cancer (GC)

P-247: Low dose extended release metoprolol (Toprol-XL®, TXL) is effective and well tolerated add-on antihypertensive therapy

Evolving TXL

TXL ([Airport Code])

Phase I study of paclitaxel (TXL), doxorubicin (ADM) and carboplatin (CBDCA) combination therapy (TAC) in patients with high-risk and recurrent endometrial cancer

Aktive Filter

Suchergebnisse filtern